153 related articles for article (PubMed ID: 15061361)
1. The discordance rate, a new concept for combining diagnostic decisions with analytical performance characteristics. 2. Defining analytical goals applied to the diagnosis of type 2 diabetes by blood glucose concentrations.
Haeckel R; Wosniok W
Clin Chem Lab Med; 2004 Feb; 42(2):198-203. PubMed ID: 15061361
[TBL] [Abstract][Full Text] [Related]
2. Discordance rate, a new concept for combining diagnostic decisions with analytical performance characteristics. 1. Application in method or sample system comparisons and in defining decision limits.
Haeckel R; Wosniok W; Puentmann I
Clin Chem Lab Med; 2003 Mar; 41(3):347-55. PubMed ID: 12705345
[TBL] [Abstract][Full Text] [Related]
3. Comparison of several point-of-care testing (POCT) glucometers with an established laboratory procedure for the diagnosis of type 2 diabetes using the discordance rate. A new statistical approach.
Püntmann I; Wosniok W; Haeckel R
Clin Chem Lab Med; 2003 Jun; 41(6):809-20. PubMed ID: 12880146
[TBL] [Abstract][Full Text] [Related]
4. Prevalence-dependent decision limits for the early detection of type 2 diabetes mellitus in venous blood, venous plasma and capillary blood during glucose challenge.
Haeckel R; Raber R; Wosniok W
Clin Chem Lab Med; 2006; 44(12):1462-71. PubMed ID: 17163824
[TBL] [Abstract][Full Text] [Related]
5. Evaluation of systematic and random factors in measurements of fasting plasma glucose as the basis for analytical quality specifications in the diagnosis of diabetes. 3. Impact of the new WHO and ADA recommendations on diagnosis of diabetes mellitus.
Hyltoft Petersen P; Brandslund I; Jørgensen L; Stahl M; de Fine Olivarius N; Borch-Johnsen K
Scand J Clin Lab Invest; 2001 May; 61(3):191-204. PubMed ID: 11386606
[TBL] [Abstract][Full Text] [Related]
6. A new concept to derive permissible limits for analytical imprecision and bias considering diagnostic requirements and technical state-of-the-art.
Haeckel R; Wosniok W
Clin Chem Lab Med; 2011 Apr; 49(4):623-35. PubMed ID: 21345158
[TBL] [Abstract][Full Text] [Related]
7. Reprint of "Influence of analytical bias and imprecision on the number of false positive results using Guideline-Driven Medical Decision Limits".
Hyltoft Petersen P; Klee GG
Clin Chim Acta; 2014 May; 432():127-34. PubMed ID: 24747109
[TBL] [Abstract][Full Text] [Related]
8. Monte Carlo simulation in establishing analytical quality requirements for clinical laboratory tests meeting clinical needs.
Boyd JC; Bruns DE
Methods Enzymol; 2009; 467():411-433. PubMed ID: 19897102
[TBL] [Abstract][Full Text] [Related]
9. Setting performance goals and evaluating total analytical error for diagnostic assays.
Krouwer JS
Clin Chem; 2002 Jun; 48(6 Pt 1):919-27. PubMed ID: 12029009
[TBL] [Abstract][Full Text] [Related]
10. Validation of capillary glucose measurements to detect glucose intolerance or type 2 diabetes mellitus in the general population.
Kruijshoop M; Feskens EJ; Blaak EE; de Bruin TW
Clin Chim Acta; 2004 Mar; 341(1-2):33-40. PubMed ID: 14967156
[TBL] [Abstract][Full Text] [Related]
11. Comparison of differing diagnostic criteria for diabetes: experience from a New Zealand community laboratory.
Florkowski C; Thompson A
N Z Med J; 1999 Sep; 112(1095):339-41. PubMed ID: 10553936
[TBL] [Abstract][Full Text] [Related]
12. A mathematical procedure to estimate the impact of a change in method on discordance or misclassification at a decision limit in laboratory method comparison studies.
Schmidt RL; Kordy MA; Genzen JR; Straseski JA; Greene DN; Lehman CM
Clin Chim Acta; 2015 Feb; 440():23-30. PubMed ID: 25444744
[TBL] [Abstract][Full Text] [Related]
13. [Prevalence of newly diagnosed type 2 diabetes, impaired glucose tolerance and abnormal fasting glucose in a high risk population. Data from the RIAD study using new diagnostic criteria for diabetes].
Köhler C; Temelkova-Kurktschiev T; Schaper F; Fücker K; Hanefeld M
Dtsch Med Wochenschr; 1999 Sep; 124(37):1057-61. PubMed ID: 10520305
[TBL] [Abstract][Full Text] [Related]
14. Does the new American Diabetes Association definition for impaired fasting glucose improve its ability to predict type 2 diabetes mellitus in Spanish persons? The Asturias Study.
Valdés S; Botas P; Delgado E; Alvarez F; Cadórniga FD
Metabolism; 2008 Mar; 57(3):399-403. PubMed ID: 18249214
[TBL] [Abstract][Full Text] [Related]
15. Diabetes screening after gestational diabetes mellitus: poor performance of fasting plasma glucose.
Cypryk K; Czupryniak L; Wilczyński J; Lewiński A
Acta Diabetol; 2004 Mar; 41(1):5-8. PubMed ID: 15057547
[TBL] [Abstract][Full Text] [Related]
16. Combination of analytical quality specifications based on biological within- and between-subject variation.
Petersen PH; Fraser CG; Jørgensen L; Brandslund I; Stahl M; Gowans E; Libeer JC; Ricós C
Ann Clin Biochem; 2002 Nov; 39(Pt 6):543-50. PubMed ID: 12564835
[TBL] [Abstract][Full Text] [Related]
17. A review of standards and statistics used to describe blood glucose monitor performance.
Krouwer JS; Cembrowski GS
J Diabetes Sci Technol; 2010 Jan; 4(1):75-83. PubMed ID: 20167170
[TBL] [Abstract][Full Text] [Related]
18. Fasting and post-glucose load--reference limits for peripheral venous plasma glucose concentration in pregnant women.
Jørgensen LG; Schytte T; Brandslund I; Stahl M; Petersen PH; Andersen B
Clin Chem Lab Med; 2003 Feb; 41(2):187-99. PubMed ID: 12667006
[TBL] [Abstract][Full Text] [Related]
19. Influence of analytical bias and imprecision on the number of false positive results using Guideline-Driven Medical Decision Limits.
Hyltoft Petersen P; Klee GG
Clin Chim Acta; 2014 Mar; 430():1-8. PubMed ID: 24362233
[TBL] [Abstract][Full Text] [Related]
20. A Markov chain probability model of glucose tolerance in post gestational diabetes follow up study.
Grassi A; Gaetano L; Pacini G; Kautzky-Willer A; Tura A
Stud Health Technol Inform; 2010; 160(Pt 2):1155-9. PubMed ID: 20841865
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
